Pioneer in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, Clasado Biosciences (‘Clasado’), has today announced the appointment of a new Research & Development Director, Dr Lucien Harthoorn.
Dr Harthoorn will oversee the scientific research that drives Clasado and its daily fibre supplement brand Bimuno® forward. In addition to Research and Development, he will be responsible for overseeing regulatory affairs, ensuring that the products developed by the business adhere to existing quality system processes and are ahead of global regulations and standards.
Commenting on his appointment, Dr Harthoorn said: “Alongside driving the overall product development strategy with the CEO, I am keen to build on the company’s great relationships with its third-party vendors and key experts to provide robust product support.
“It’s an exciting time to join the business. Bimuno is experiencing significant growth, finding new applications and formats, expanding into multiple therapeutic areas and advancing towards clinical use. I’m hoping to make my mark and design a robust development programme that will determine where the products can go next and to capitalise on market trends and needs.”
Dr Harthoorn will work with the senior leadership team to develop the long-term strategy of the business, translating scientific outcomes from the company’s comprehensive clinical testing into commercial opportunities. In addition, he will deliver technical information, progress and results from the research, ensuring key stakeholders including shareholders, partners and employees are kept up to date with the latest developments.
Per Rehné, Clasado’s CEO, added: “We’re delighted to welcome Dr Harthoorn to the position and to the business. His proven track record in biomedical sciences and nutraceutical technology, as well as research excellence, makes him a great addition to the team. His enviable experience in delivering comprehensive research and development programmes will prove invaluable as he designs and oversees pre-clinical and clinical studies to further boost the impressive credentials of Bimuno.
“Our culture at Clasado is one of continuous growth, collaboration and market agility, and it’s important to us that every single member of the team shares our vision. We feel that Dr Harthoorn’s skills, creativity and pragmatism will be a great fit for our executive team.”
To find out more about Clasado Biosciences, please visit www.clasado.com